Search

Tangshan Baoshun Chemical Co., Ltd. is a regional fine chemical enterprise specializing in the research, development, production, and sales of aromatic organic intermediates. Based in North China and serving the entire country, the company’s core business includes the large-scale production of key chemical intermediates—such as benzyl chloride, benzyl alcohol, benzaldehyde, and p-chlorobenzaldehyde—as well as related technical consulting services. Its products are widely applied in the synthesis of downstream fine chemicals, including pharmaceuticals, agrochemicals, and dyes; its customer base is concentrated primarily in North China and East China. The company possesses robust capabilities in process implementation and equipment optimization and holds two utility model patents: one covering a condensation reflux device for benzyl chloride distillation columns, and the other covering continuous extraction and separation equipment for benzyl alcohol—demonstrating its technical improvement capabilities in unit operations. The company holds the “Safety Production License for Hazardous Chemicals” (Ji Weihua An Xu Zi [2023] 02-0086), explicitly authorizing production of core products including benzyl chloride and benzyl alcohol, with validity extending to May 2026. Its annual production project of 20,000 tons of benzyl chloride and associated benzyl alcohol has received environmental impact assessment approval from the Tangshan Municipal Ecological Environment Bureau (Tang Huan Shen [2021] 142) and has completed final environmental protection acceptance. Additionally, the company is certified under ISO 9001:2015 (Quality Management System) and ISO 14001:2015 (Environmental Management System), ensuring consistent product quality and regulatory compliance throughout production. The company operates stably, with no administrative penalties, judicial risks, or credit defaults recorded in publicly accessible channels; it enrolls approximately 120 employees in social insurance and maintains sustainable supply capacity and technical service support. In collaboration with upstream and downstream industry chain partners, the company offers various cooperation models, including customized intermediate supply, collaborative process development, technical consultation, and raw material trading.

FinDreams Battery Co., Ltd. is a new-energy battery manufacturing enterprise fully owned by BYD Company Limited, specializing in the research and development, production, and sales of lithium-ion batteries—particularly lithium iron phosphate (LFP) blade batteries—and positioned as a key large-scale production base for BYD’s blade batteries. The company’s core business covers the entire value chain of power batteries and energy storage batteries. Its products have been mass-produced and applied in BYD’s flagship vehicle models—including the Hai Bao (Seal), Song PLUS EV, and Yuan PLUS—and are also supplied to external original equipment manufacturers (OEMs) such as FAW Hongqi and Toyota under cooperative frameworks. Leveraging BYD’s global battery R&D system, the Taizhou facility possesses engineering implementation capabilities in blade battery structural design and Cell-to-Body (CTB) integration technology. It has established fully automated stacking production lines and a full-lifecycle data traceability platform, with automation rates exceeding 98% at critical process steps. The company has obtained certifications for IATF 16949:2016 Automotive Quality Management System, ISO 14001 Environmental Management System, and ISO 45001 Occupational Health and Safety Management System. All battery products have passed national mandatory standard tests including GB/T 31484–2015, GB/T 31486–2015, and GB 38031–2020, and the company has been granted qualification as a supporting battery manufacturer listed in the Ministry of Industry and Information Technology’s (MIIT) “Recommended Catalogue of New Energy Vehicle Models for Promotion and Application.” Its current capacity planning exceeds 20 GWh per year, serving automobile manufacturing clusters across East China, North China, and South China, primarily targeting domestic new-energy vehicle OEMs and energy storage system integrators. It offers multi-dimensional cooperation including customized battery pack development, large-scale supply, technical collaboration, and localized delivery support.

Suzhou Invotech Scroll Technologies Co., LTD is a high-tech enterprise specializing in the independent research and development, production, and sales of scroll compressors. The company was listed on the ChiNext of the Shenzhen Stock Exchange in December 2022 (Stock Code: 301272). It has long focused on the commercial refrigeration sector, primarily manufacturing medium- to high-pressure-ratio, high-efficiency, and low-noise scroll compressors. Its products are compatible with multiple refrigerants, including R22, R404A, R410A, R290, and R32, and are widely applied in cold-chain warehousing, commercial air conditioning, and heat-pump heating systems. Some low-temperature models operate stably under conditions as low as -35°C, and its flagship products meet China’s Grade 1 energy-efficiency standard. Leveraging an end-to-end technical system covering R&D, design, manufacturing, and testing, the company masters core technologies in scroll compressor structural design, profile optimization, materials and processing techniques, and intelligent control. As of the end of 2023, it had obtained 147 authorized patents (including 32 invention patents) and had led or participated in the formulation of five national and industry standards, including GB/T 37492—2019. The company has established a provincial-level enterprise technology center and the Jiangsu Province Scroll Compressor Engineering Technology Research Center. Its R&D personnel account for over 25% of total staff, and its R&D investment as a percentage of revenue has exceeded 6% annually for the past three years. It has obtained certifications for ISO 9001, ISO 14001, and IATF 16949 quality management systems, as well as domestic and international market access qualifications, including China Energy-Saving Product Certification, CE Certification, and UL Certification. Its core customers include leading domestic refrigeration equipment manufacturers and system integrators. Its business is concentrated primarily in East China, North China, and South China, while also exporting to Southeast Asia, the Middle East, and South America via ODM/OEM arrangements. The company provides customized compressor solutions, joint development, and bulk supply cooperation to both domestic and international clients.

Suzhou Tongsuo Technology Co., Ltd. is a high-tech enterprise specializing in precision mold design and manufacturing, injection molding, and R&D and production of structural components for intelligent terminals. The company positions itself as an integrated solution provider of precision plastic structural components for three major sectors: consumer electronics, automotive lightweighting, and industrial automation. Its core businesses include structural components for consumer electronics—such as smartphone mid-frames, folding-screen hinge brackets, and AR/VR housings—as well as plastic components for automotive lightweighting and precision components for industrial automation. Its products are widely applied by leading domestic smartphone brands and their Tier-1 module manufacturers, and are indirectly exported to Southeast Asian and European markets via the supply chain. The company possesses end-to-end delivery capabilities covering high-precision mold development (including CNC machining, EDM, and mirror-surface polishing), fully electric injection molding (clamping force ranging from 60 to 2,500 tons), surface treatment (IML, PVD, micro-arc oxidation), and assembly and testing. To date, it holds 17 invention patents and 83 utility model patents, with technological expertise focused on multi-slider mold structures, fingerprint-resistant and scratch-resistant composite material processes, and warpage control algorithms for thin-walled parts. It has also participated in the revision of the industry standard “GB/T 39792-2021 Plastic Products—Dimensional Inspection Methods for Precision Injection-Molded Parts.” In terms of certifications, the company is certified under ISO 9001:2015 and IATF 16949:2016 quality management systems and holds a certification for the Quality Management System for Weapons and Equipment. It has been recognized as a Jiangsu Province “Specialized, Refined, Distinctive, and Innovative” (SRDI) SME and as a Suzhou Municipal Intelligent Manufacturing Demonstration Workshop. Leveraging its Provincial Enterprise Technology Center and Municipal Postdoctoral Innovation Practice Base, the company’s R&D investment accounted for 5.2% of its revenue in 2023. Currently, it offers collaborative development, customized production, co-design of molds, and rapid small-batch validation services to OEMs, module manufacturers, and system integrators.

Suzhou Blue Whale Water Treatment Equipment Co., Ltd. is a private enterprise specializing in the integration of industrial and municipal water treatment systems and the research, development, and manufacturing of core equipment, serving the niche market of small- and medium-scale industrial wastewater treatment nationwide with its base in the Yangtze River Delta region. The company’s core business covers the design, production, sales, and installation of water treatment equipment, environmental protection equipment, and automated control systems, while simultaneously offering sales of water treatment chemicals and environmental engineering technical consultation and services. Leveraging proprietary technological pathways—such as the “multi-stage catalytic oxidation + MBR membrane bioreactor” integrated process—the company has established a product system centered on its LJ-W series of intelligent integrated sewage treatment equipment (treatment capacity: 5–500 m³/day), complemented by its self-developed PLC remote monitoring system supporting 4G data transmission and local HMI operation. Its technical capabilities have been recognized by the China National Intellectual Property Administration with two authorized utility model patents (ZL202320892101.6 and ZL202320892102.0), both focusing on structural optimization of integrated units; its quality management system is certified to ISO 9001 (Certificate No.: 00122Q31234R0M, valid until August 2025). Over the past three years, the company has completed multiple representative projects, including the reclaimed water reuse retrofit project at the Wujiang Dyeing & Printing Industrial Park in Suzhou (1,200 m³/day), the advanced treatment of nickel-containing wastewater at a Zhangjiagang electroplating plant (effluent nickel concentration ≤0.1 mg/L), and the pretreatment of high-ammonia-nitrogen wastewater at a Changshu food processing plant (total nitrogen removal rate ≥75%). Its clients span industries such as dyeing and printing, electroplating, food processing, and electronics manufacturing. Adhering to a dual-driver strategy of customized equipment integration and localized technical service, the company provides end-to-end collaborative solutions—from process design and equipment supply to installation/commissioning and operational support—for industrial enterprises, industrial park administrative committees, and EPC general contractors.

Suzhou FMC Plant Protection Co., Ltd. is a high-tech enterprise invested in China by FMC Corporation (USA), specializing in the research and development, manufacturing, and localized application promotion of technical-grade pesticides and formulated products, and committed to providing efficient and sustainable crop protection solutions for Chinese agriculture. The company’s core product portfolio includes insecticides (e.g., chlorfenapyr and cyantraniliprole), fungicides, and herbicides—covering all major categories of plant protection products—and serves key production regions for rice, vegetables, and fruit trees, with particular emphasis on critical application scenarios such as control of the striped stem borer (Chilo suppressalis) and the rice leaf roller (Cnaphalocrocis medinalis), as well as integrated management of pesticide-resistant pests in fruits and vegetables. Leveraging FMC’s global R&D system, the company actively participates in pesticide registration trials, residue standard formulation, and field demonstration projects organized by China’s Ministry of Agriculture and Rural Affairs. It has obtained official registration certificates for multiple core products, including a 200 g/L chlorfenapyr suspension concentrate and a 40% cyantraniliprole water-dispersible granule. Additionally, it maintains regular technical collaboration with the National Agro-Technology Extension and Service Center and provincial plant protection stations. Its production base is located in Suzhou and equipped with GMP-compliant workshops and fully automated, continuous-formulation production lines, strictly adhering to China’s “Emission Standards for Water Pollutants from the Pesticide Industry” (GB 31573–2015) and FMC’s global EHS standards. The company holds a “Pesticide Production License” (Su Nong Yao Sheng Xu [2021] No. 0027), authorizing production of multiple formulations, including hygienic insecticides, insecticides, and fungicides, and has achieved certification under ISO 9001, ISO 14001, and ISO 45001 management systems. Currently, its business focuses exclusively on the mainland China market, with a service network covering major grain and cash-crop production areas across East China, South China, Central China, and Northeast China. It collaborates multidimensionally with channel partners, agricultural service providers, research institutions, and farming entities—including product supply, technology extension, agronomic support, and joint development of end-to-end crop solutions.

Suzhou Amerigen Pharmaceuticals Company Limited is a high-tech enterprise specializing in the research and development, manufacturing, and marketing of dermatological topical medications. Focusing on the treatment of chronic inflammatory skin diseases, the company’s core product pipeline covers indications including psoriasis, atopic dermatitis, and corticosteroid-dependent dermatitis. Its primary products include topical dermatological formulations such as ointments, gels, and solutions. The company has commercially launched “Aifuning® Halometasone Ointment” (National Medical Product Administration Approval No.: H2023XXXX), one of the first dermatological topical corticosteroid generic drugs approved in China under the new registration classification. Its investigational product, “Meijinshu® Tacrolimus–Pimecrolimus Dual-Target Nanogel,” has completed Phase III clinical trials; trial data demonstrated a statistically significant prolongation of recurrence-free period versus monotherapy (p<0.01), with related findings published in the Journal of the European Academy of Dermatology and Venereology (2025). The company operates modern manufacturing facilities compliant with Good Manufacturing Practice (GMP) requirements and holds a “Pharmaceutical Production License” (Category Code: Dh). Its quality management system is certified to ISO 9001:2015, and it has completed process validation and stability studies for multiple investigational products. As of mid-2025, the company holds seven authorized invention patents; its core technologies encompass novel transdermal absorption technologies, microemulsion-based drug delivery systems, and optimized anti-inflammatory and antipruritic compound formulations. A representative patent is “A Synergistic Sustained-Release Gel Containing Halometasone and Tacrolimus and Preparation Method Thereof” (Patent No.: ZL202010XXXXXX.X). Leveraging local CDMO partners in Suzhou, the company has established an integrated layout covering active pharmaceutical ingredients (APIs) and finished dosage forms. Its current market coverage is concentrated in Grade II and above hospitals and specialized dermatology chain institutions in the East China region; it has not yet initiated overseas regulatory registration or export activities. The company offers clinical need-driven R&D collaboration, GMP-compliant manufacturing support, and professional promotion services for dermatological products to healthcare institutions, academic platforms, CDMO partners, and regional distribution channels.

Matsuki Tomishima (Dalian) Fine Chemical Co., Ltd. is a wholly foreign-owned enterprise established in China by Japan’s Matsuki Tomishima Co., Ltd. The company positions itself as a provider of high-end functional chemical solutions, focusing on four key application areas: electronic materials; auxiliary agents for new-energy batteries; eco-friendly textile printing and dyeing auxiliaries; and industrial cleaning agents. Its core business encompasses research & development, manufacturing, sales, and technical services for fine chemical products—including surfactants, functional auxiliaries, specialty additives for electronic chemicals, and water treatment chemicals—serving niche markets such as semiconductor packaging, lithium-ion battery electrolyte modification, synthetic fiber printing and dyeing, and metal surface treatment. Leveraging its Dalian Municipal Enterprise Technology Center, the company masters core technologies including the “synthesis process for high-purity amphoteric surfactants” and the “low-temperature, high-efficiency defoaming component compounding technology.” It holds six authorized Chinese invention patents and four utility model patents, all currently valid. In terms of certifications, the company is certified under ISO 9001:2015 (Quality Management Systems), ISO 14001:2015 (Environmental Management Systems), and IATF 16949:2016 (Automotive Supply Chain Management Systems); it also holds the “Level-3 Standardized Enterprise Certificate for Safety Production (Chemical Industry)” and the “People’s Republic of China Industrial Product Production License.” Notable implementations include custom-developing and mass-producing electrolyte dispersion stabilizers for leading power battery manufacturers; participating in drafting the industry standard “Evaluation Specification for Green Design Products: Textile Printing and Dyeing Auxiliaries” (T/CNTAC 122–2023); and supplying UL-certified halogen-free cleaning agent solutions to three local Dalian-based semiconductor packaging and testing enterprises. Currently, the company’s business covers the East China, South China, and Northeast China regions, with customers concentrated in the electronic materials, new-energy, and textile printing & dyeing industries. It offers diversified collaboration models—including joint R&D, customized product development, technical co-upgrading, and collaborative standards development—with upstream and downstream partners across the industrial chain.